Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal–regulated kinase inhibitors and rapamycin [PDF]
, 2009 Patrick Frost +4 more
openalex +1 more source
Cycling Quiescence in Temozolomide Resistant Glioblastoma Cells Is Partly Explained by microRNA-93 and -193-Mediated Decrease of Cyclin D. [PDF]
Front Pharmacol, 2019 Munoz JL +6 more
europepmc +1 more source
Runt-related transcription factor 1 (RUNX1; AML1); runt-related transcription factor 1 translocated to 1 (cyclin D-related) (RUNX1T1; ETO) [PDF]
, 2009 Shuo Dong
openalex +1 more source
ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner. [PDF]
Sci Rep, 2018 Suk FM +6 more
europepmc +1 more source
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway [PDF]
, 2010 Xinliang Mao +16 more
openalex +1 more source
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis. [PDF]
Cancer Res, 2018 Oh SJ +16 more
europepmc +1 more source
Ras signals principally via Erk in G1 but cooperates with PI3K/Akt for Cyclin D induction and S-phase entry. [PDF]
Cell Cycle, 2019 Vasjari L +4 more
europepmc +1 more source
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway. [PDF]
Nat Commun, 2018 Gao A +15 more
europepmc +1 more source
D-Type Cyclins and Their Cyclin-dependent Kinases: G1 Phase Integrators of the Mitogenic Response
Cold Spring Harbor Symposia on Quantitative Biology, 1994 M. Matsuoka +4 more
openaire +3 more sources